This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Evaluation of Priovant Therapeutics P3 Data on Brepocitinib for Treating Dermatomyositis
Ticker(s): PRIOVANT THERAPEUTICS, PFE, ARGX, RHHBY, ROIVWho's the expert?
Institution: Johns Hopkins
- Assistant Professor of Medicine in the Division of Rheumatology at the Johns Hopkins School of Medicine & Director of Clinical Trials at the Johns Hopkins Myositis Center.
- Actively manages 50+ patients with dermatomyositis.
- Research focus is in overlap myositis in particular studying the spectrum of skeletal myopathy in systemic sclerosis and investigating novel therapeutics in refractory dermatomyositis.
Interview GoalThis call will focus on the landscape of Dermatomyositis and the potential of Priovant Therapeutics Brepocitinib
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
